Scientific Reports · 2019 · 39 citations · 36 references
MedicineOncologyPharmacologyCell SignalingMolecular OncologySignal TransductionCancer Cell SignalingMolecular Tumor ProfilingOncogenic Signaling PathwaysSignal Transduction In CancerSquamous Cell CarcinomaTherapeutic ResistanceAnticancer Drug ResistanceCetuximab TherapyEgfr InhibitionEpidermal Growth Factor Receptor SignalingGenetic Alterations In ResistanceOncogenic Signaling NetworksPlasminogen ActivatorsTherapeutic Resistance Mechanisms
Drug resistance to anti-cancer agents is a major concern regarding the successful treatment of malignant tumors. Recent studies have suggested that acquired resistance to anti-epidermal growth factor receptor (EGFR) therapies such as cetuximab are in part caused by genetic alterations in patients with oral squamous cell carcinoma (OSCC). However, the molecular mechanisms employed by other complementary pathways that govern resistance remain unclear. In the current study, we performed gene expression profiling combined with extensive molecular validation to explore alternative mechanisms driving cetuximab-resistance in OSCC cells. Among the genes identified, we discovered that a urokinase-type plasminogen activator receptor (uPAR)/integrin β1/Src/FAK signal circuit converges to regulate ERK1/2 phosphorylation and this pathway drives cetuximab-resistance in the absence of EGFR overexpression or acquired EGFR activating mutations. Notably, the polyphenolic phytoalexin resveratrol, inhibited uPAR expression and consequently the signaling molecules ERK1/2 downstream of EGFR thus revealing additive effects on promoting OSCC cetuximab-sensitivity in vitro and in vivo. The current findings indicate that uPAR expression plays a critical role in acquired cetuximab resistance of OSCC and that combination therapy with resveratrol may provide an attractive means for treating these patients.
36
Jennifer R. Grandis, Mona F. Melhem, E. Leon Barnes et al. · Cancer · 1996 · 370 citations · Full text
Yelena Y. Janjigian, Egbert F. Smit, Harry J.M. Groen et al. · Cancer Discovery · 2014 · 355 citations · Full text
Kinesin Family member 4A: A Potential Predictor for Progression of Human Oral Cancer
Yasuyuki Minakawa, Atsushi Kasamatsu, Hirofumi Koike et al. · PLoS ONE · 2013 · 107 citations · Full text